Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Recurrence × Methylprednisolone × Clear all

Phase

Phase 2 12 Phase 1 3 Phase NA 1 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Leukemia 5 Lymphoma, Follicular 4 Lymphoma 4 Leukemia, Biphenotypic, Acute 4 Lymphoma, Non-Hodgkin 3 Leukemia, Myeloid, Acute 3 Burkitt Lymphoma 3 Multiple Myeloma 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphohistiocytosis, Hemophagocytic 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Graft vs Host Disease 2 Epstein-Barr Virus Infections 2 Recurrence 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Pneumonia, Pneumocystis 1 Pneumonia 1 Neurotoxicity Syndromes 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Lymphoma, Large-Cell, Anaplastic 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Myeloid 1 Hodgkin Disease 1 Hiccup 1

Interventions

Dexamethasone 21 Rituximab 13 Paclitaxel 10 Gemcitabine 10 Cisplatin 10 pomalidomide 9 Lenalidomide 9 Carboplatin 8 Bortezomib 8 Cyclophosphamide 7 Drug Therapy 5 Cytarabine 5 selinexor 4 daratumumab 4 carfilzomib 4 Temozolomide 4 Doxorubicin 4 Docetaxel 4 Bevacizumab 4 Aspirin 4 tisagenlecleucel 3 ibrutinib 3 Vincristine 3 Prednisone 3 Cetuximab 3 Calcium Dobesilate 3 galiximab 2 eculizumab 2 durvalumab 2 blinatumomab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06097364 2026-02-06

OLYMPIA-2

Regeneron Pharmaceuticals

Phase 3 Active not recruiting

Lymphoma, Follicular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡